메뉴 건너뛰기




Volumn 22, Issue 3, 2012, Pages 503-505

Choroidal neovascularization of optic disk melanocytoma treated with bevacizumab

Author keywords

Angiogenesis; Malignancy; Melanoma; Vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB;

EID: 84863336487     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000060     Document Type: Article
Times cited : (8)

References (5)
  • 1
    • 4444267117 scopus 로고    scopus 로고
    • Melanocytoma of optic disc in 115 cases: The 2004 Samuel Johnson Memorial Lecture, part 1
    • Shields JA, Demirci H, Mashayekhi A, Shields CL. Melanocytoma of optic disc in 115 cases: the 2004 Samuel Johnson Memorial Lecture, part 1. Ophthalmology 2004; 111: 1739-1746.
    • (2004) Ophthalmology , vol.111 , pp. 1739-1746
    • Shields, J.A.1    Demirci, H.2    Mashayekhi, A.3    Shields, C.L.4
  • 2
    • 33845335447 scopus 로고    scopus 로고
    • Successful management of melanocytoma-associated choroidal neovascularization with photodynamic therapy
    • Chalam KV, Gupta SK, Shah GY, Agarwal S. Successful management of melanocytoma-associated choroidal neovascularization with photodynamic therapy. Eur J Ophthalmol 2006; 16: 776-778.
    • (2006) Eur J Ophthalmol , vol.16 , pp. 776-778
    • Chalam, K.V.1    Gupta, S.K.2    Shah, G.Y.3    Agarwal, S.4
  • 3
    • 34248580506 scopus 로고    scopus 로고
    • Management of neovascular age-related macular degeneration
    • Schmidt-Erfurth UM, Pruente C. Management of neovascular age-related macular degeneration. Prog Retin Eye Res 2007; 26: 437-451.
    • (2007) Prog Retin Eye Res , vol.26 , pp. 437-451
    • Schmidt-Erfurth, U.M.1    Pruente, C.2
  • 4
    • 0141430051 scopus 로고    scopus 로고
    • Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epitheliumderived factor
    • Schmidt-Erfurth U, Schlötzer-Schrehard U, Cursiefen C, Michels S, Beckendorf A, Naumann GO. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epitheliumderived factor. Invest Ophthalmol Vis Sci 2003; 44: 4473-4480.
    • (2003) Invest Ophthalmol Vis Sci , vol.44 , pp. 4473-4480
    • Schmidt-Erfurth, U.1    Schlötzer-Schrehard, U.2    Cursiefen, C.3    Michels, S.4    Beckendorf, A.5    Naumann, G.O.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.